Skip to main content
. 2014 Jun 16;2014:149750. doi: 10.1155/2014/149750

Figure 2.

Figure 2

Prescription frequencies of aristolochic acid (AA) related and Xi-Xin Chinese herbal products (CHPs) in 90,477 patients with ESRD (end-stage renal disease), stratified by sex.